Table 2 Histopathological and GFAP immune reactivity findings in BSS and imatinib-injected eyes
| Â | Group F (NÂ =Â 9) | Group E (NÂ =Â 7) | Group D (NÂ =Â 8) | Group C (NÂ =Â 9) | Group B (NÂ =Â 10) | Group A (NÂ =Â 9) |
|---|---|---|---|---|---|---|
Intra and subretinal hemorrhage | 0 | 0 | 0 | 0 | 0 | 0 |
Preserved retinal integrity | 9 | 7 | 7 | 3 | 3 | 1 |
Preserved RPE integrity | 9 | 7 | 7 | 3 | 4 | 2 |
Retinal atrophy | 0 | 0 | 0 | 0 | 7 | 7 |
Remarkable GFAP | 0 | 0 | 0 | – | – | – |